Probiotica Approach to Combat multi-resistent Enterocci: A Cross-over Clinical Trial on the Effect of Probiotics on Nosocomial Spread of CC17 Enterococcus faecium

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON25438

Enrollment

640

Registered

2007-04-19

Start date

2007-05-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

infection control

Interventions

Probiotics, twice daily

Eligibility

Inclusion criteria

Inclusion criteria: All admissions on two wards (gastroenterology/nephrology and geriatrics) of the University Medical Center Utrecht, where ARE colonization is endemic

Exclusion criteria

Exclusion criteria: No exclusion criteria

Design outcomes

Primary

Measure	Time frame
Difference in acquisition rate of perianal ARE-colonization between the probiotic period and the control period	—

Secondary

Measure	Time frame
Difference in prevalence of perianal ARE-colonization between the probiotic period and the control period	—

Contacts

Public ContactM.J.A. Regt, de

University Medical Center Utrecht Department of Medical Microbiology, PO BOX 85500

m.deregt@umcutrecht.nl+31 30-2505006

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)